Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
FDA Warns Against Use of Compounded Versions of Ozempic, Wegovy Some compounded versions of Ozempic and Wegovy use salt forms of the active ingredient which have not been tested or approved by the agency. June 1, 2023 Irvin Jackson Add Your Comments Consumers should be careful about the use of compounded versions of the diabetes drugs Ozempic and Wegovy, because they may be made with unauthorized and untested, ingredients, according to a new warning from federal drug regulators. The U.S. Food and Drug Administration (FDA) issued a drug statement communication on May 31, warning about risks that may result from the increasing use of Ozempic and Wegovy for weight loss, which are often made by compounding pharmacies. However, the agency indicates that some compounding pharmacies are using unapproved versions of the active ingredient, semaglutide, which may put users at risk and which has been linked to adverse event reports from patients. Ozempic (semaglutide) was originally approved for the treatment of people with Type 2 diabetes. However, in recent months Ozempic has been widely prescribed for weight loss. Although the diabetes drug Wegovy is approved for weight loss use, Ozempic is not and it is increasingly prescribed “off-label” as a diet medication. Compounded Ozempic and Wegovy May Use Unsafe Ingredients The move toward using the two drugs as weight loss treatments, as well as other supply chain factors, have resulted in a shortage of the two medications. During such shortages, compounding pharmacies may be allowed to make in-house versions of the drugs for customers, but they must meet FDA standards and use approved ingredients. Both Ozempic and Wegovy are currently listed on the FDA’s drug shortage list, which makes them eligible for compounding. However, the FDA does not review compounded versions of medications on the drug shortage list for safety, quality or effectiveness, the FDA warns. According to the FDA warning, the agency has received adverse event reports after patients used compounded versions of these drugs, and warns that it has also received reports that some compounding pharmacies are using a salt form of semaglutide, such as semaglutide sodium and semaglutide acetate. The salt forms of semaglutide are different active ingredients than the semaglutide used in standard Ozempic and Wegovy, the agency warns. The FDA indicates it is unaware of any means of compounding the salt forms of semaglutide which would meet the agency’s requirements for compounding the two drugs. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION On April 27, the FDA sent a letter to the National Association Boards of Pharmacy, warning them about the problem. “We are aware that in some cases compounders may be using salt forms of semaglutide, including semaglutide sodium and semaglutide acetate,” the agency wrote. “We are not aware of any basis for compounding a drug using these semaglutide salts that would meet federal law requirements that limit the types of active ingredients that can be used in compounding.” FDA Recommendations for Patients and Doctors The agency does not say what kinds of adverse events have been reported in connection to the compounded drugs, nor does it say what types of adverse events may be linked to the use of semaglutide salts in compounded drugs. The FDA warns patients to be aware of the risk of compounding pharmacies using semaglutide salts, indicating they have not been proven to be safe or effective. Patients should only obtain the prescription-only drugs with a prescription and from a licensed health care provider. They should also only use compounding pharmacies which are state-licensed, or outsourcing facilities registered with the FDA, the agency advises. Healthcare professionals should also be aware of the problem if they are considering working with compounders to meet the needs of patients, the FDA advises. Ozempic Hair Loss Concerns The warning comes amid increasing reports that Ozempic side effects have been linked to hair loss when using the diabetes drug as a weight loss treatment. Some doctors have claimed hair loss after Ozempic use is a natural result of rapid weight loss. This effect is known as telogen effluvium. However, Ozempic may also cause hormonal shifts which can also trigger early onset pattern hair loss in men and women, known as androgenic alopecia, which is progressive and continues to worsen over time. This can lead to permanent hair loss, some health experts warn. Last month the founder of The American Hair Loss Association (AHLA) and The International Alliance of Hair Restoration Surgeons, warned against misuse of Ozempic for weight loss in an editorial in Dermatology Times, indicating that the hair loss experts do not recommend the off-label use of the diabetes drug. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Compounding Pharmacy, Diabetes, Diabetes Drugs, Hair Loss, Ozempic, Wegovy, Weight Loss Find Out If You Qualify for Ozempic or Wegovy Compensation More Ozempic, Wegovy and Mounjaro Lawsuit Stories Ozempic, Wegovy Kidney Side Effects Highlighted in New Study October 10, 2025 Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue October 7, 2025 Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s October 3, 2025 0 Comments FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Side Effects Hidden for Decades, Lawsuit Alleges (Posted: yesterday) A woman’s Depo-Provera lawsuit says the manufacturers’ failure to warn doctors and patients of the risk of intracranial meningioma led to her developing two brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOver 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (10/06/2025)Depo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025) Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: 4 days ago) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025) MDL Sought for Lyft Lawsuits Over Sexual Assaults by Drivers (Posted: 5 days ago) A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJury Finds Uber Failed To Protect Passengers, But Is Not Liable for Sexual Assault (10/01/2025)Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (09/25/2025)Two Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue October 7, 2025
Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s October 3, 2025
Depo-Provera Side Effects Hidden for Decades, Lawsuit Alleges (Posted: yesterday) A woman’s Depo-Provera lawsuit says the manufacturers’ failure to warn doctors and patients of the risk of intracranial meningioma led to her developing two brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOver 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (10/06/2025)Depo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)
Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: 4 days ago) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)
MDL Sought for Lyft Lawsuits Over Sexual Assaults by Drivers (Posted: 5 days ago) A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJury Finds Uber Failed To Protect Passengers, But Is Not Liable for Sexual Assault (10/01/2025)Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (09/25/2025)Two Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025)